Karma Clinical Trials /ID# 153876

St. John's, Newfoundland and Labrador A1A 4Y3

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) — Completed